Financial Performance - The company's revenue for Q3 2021 was ¥250,529,503.26, a decrease of 18.22% compared to the same period last year[3]. - The net profit attributable to shareholders was -¥15,287,866.70, a decline of 139.38% year-on-year[3]. - The basic earnings per share were -¥0.03, down 137.50% from the previous year[3]. - Total operating revenue for Q3 2021 reached ¥778,715,206.97, an increase of 25.9% compared to ¥618,222,857.70 in the same period last year[19]. - Net profit for the period was ¥45,530,964.41, a significant increase of 66.3% compared to ¥27,393,862.69 in Q3 2020[20]. - The net profit attributable to the parent company was ¥45,997,058.06, compared to ¥30,312,498.41 in the previous year, reflecting a growth of 51.6%[21]. - Basic and diluted earnings per share were both ¥0.09, up from ¥0.06 in the same quarter last year[21]. Assets and Liabilities - Total assets increased to ¥1,823,666,887.60, representing a growth of 22.37% compared to the end of the previous year[4]. - The company’s equity attributable to shareholders increased by 10.27% to ¥358,341,841.80 compared to the end of the previous year[4]. - Current assets decreased to RMB 345,591,880.01 from RMB 400,339,680.33, representing a decline of about 13.7%[15]. - Total liabilities increased to RMB 1,200,000,000.00, reflecting the company's ongoing financing activities[16]. - The company reported a total liability of ¥1,464,741,986.26, up from ¥1,153,320,851.28 year-on-year, reflecting a growth of 27%[20]. - The company reported a total liability of 1,153,320,851.28 CNY, reflecting a substantial increase in non-current liabilities due to the new lease accounting standard[30]. Cash Flow - The company's cash flow from operating activities was ¥30,096,984.01, a decrease of 76.12% year-to-date[8]. - Cash flow from operating activities generated a net amount of ¥30,096,984.01, a decrease of 76.2% from ¥126,012,622.21 in Q3 2020[24]. - Cash inflow from operating activities totaled ¥817,392,899.74, compared to ¥703,836,691.68 in the previous year, indicating a growth of 16.1%[24]. - The net cash flow from investment activities was 41,391,162.83 CNY, a significant improvement compared to the previous year's negative cash flow of -372,292,601.27 CNY[25]. - The financing activities generated a net cash outflow of -105,051,596.72 CNY, contrasting with a net inflow of 167,748,901.29 CNY in the same period last year[25]. Investments and Expenses - The company reported a 39.16% increase in investment income, amounting to ¥71,796,478.78, due to the sale of a subsidiary[8]. - Research and development expenses increased to ¥1,931,821.18, compared to ¥210,546.32 in the same period last year, showing a substantial rise[20]. - The company invested 33,819,347.53 CNY in fixed assets and intangible assets, up from 25,019,471.58 CNY in the previous year[25]. Changes in Financial Position - The company completed a capital increase of RMB 24 million for its wholly-owned subsidiary, Guangzheng Construction, raising its registered capital to RMB 49 million[12]. - The company received performance compensation payments totaling RMB 384,677,343.79 related to the acquisition of Guangzheng New Vision Ophthalmology, reflecting ongoing legal proceedings regarding asset restructuring[13]. - The company is adapting to the new lease accounting standards, which has resulted in significant adjustments to its financial statements[26].
光正眼科(002524) - 2021 Q3 - 季度财报